A γ34.5 mutant of herpes simplex 1 causes severe inflammation in the brain

Neuroscience

Volumn 83, Issue 4, 1998, Pages 1225-1237

  McMenamin, M M ^a   Byrnes, A P ^a   Charlton, H M ^a   Coffin, R S ^b   Latchman, D S ^b   Wood, M J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Gene transfer; HSV 1; Inflammation; Neuroimmunology; Neurovirulent; Viral vector

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELLULAR IMMUNITY; CONTROLLED STUDY; ENCEPHALITIS; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; STRAIN DIFFERENCE; VIRUS MUTATION; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRAIN; C3H MOUSE; CAUDATE NUCLEUS; CELL LINE; GENE VECTOR; GENETICS; HAMSTER; IMMUNOLOGY; INFLAMMATION; MOUSE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RAT STRAIN; SPECIES DIFFERENCE; VIROLOGY; VIRULENCE; VIRUS REPLICATION; WEIGHT REDUCTION;

BETA GALACTOSIDASE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMALS; ANTIGENS, VIRAL; BETA-GALACTOSIDASE; BRAIN; CAUDATE NUCLEUS; CELL LINE; CRICETINAE; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; RATS; RATS, INBRED STRAINS; SPECIES SPECIFICITY; VIRULENCE; VIRUS REPLICATION; WEIGHT LOSS;

EID: 0032037595     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00513-7     Document Type: Article

References (59)

1. Babu J. S., Thomas J., Kanangat S., Morrison L. A., Knipe D. M., Rouse B. T. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:1996;101-107.
2. Banks T. A., Allen E. M., Dasgupta S., Sandri-Golden R., Rouse B. T. Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate early protein ICP 27 of herpes simplex virus. J. Virol. 67:1991;613-616.
3. Bloom D. C., Maidment N. T., Tan A., Dissette V. B., Feldman L. T., Stevens J. G. Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Molec. Brain Res. 31:1995;48-60.
4. Brehm M. A., Bonneau R. H., Knipe D. M., Tevethia S. S. Immunization with a replication defective mutant of herpes simplex virus type-1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1. J. Virol. 71:1997;3534-3544.
5. Byrnes A. P., MacLaren R. E., Charlton H. M. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression and demyelination. J. Neurosci. 16:1996;3045-3055.
6. Byrnes A. P., Rusby J. E., Wood M. J. A., Charlton H. M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 66:1995;1015-1024.
7. Byrnes A. P., Wood M. J. A., Charlton H. M. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3:1996;644-651.
8. Chan W. L., Javanovic T., Lukie M. L. Infiltration of immune T cells in the brain of mice with herpes simplex virus-induced encephalitis. J. Neuroimmunol. 23:1989;195-201.
9. Chiocca E. A., Choi B. B., Cai W., DeLuca N. A., Schaffer P. A., DiFiglia M., Breakefield X. O., Martuza R. L. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol. 2:1990;739-746.
10. -. J. Virol. 64:1990;1014-1020.
11. Coffin R. S., Howard M. K., Cumming D. V. E., Dollery C. M., McEwan J., Yellon D. M., Marber M. S., MacLean A. R., Brown S. M., Latchman D. S. Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther. 3:1996;560-566.
12. Doherty P. C., Allan W., Eichelberger M., Carding S. R. Role of αβ and γδ T cell subsets in viral immunity. A. Rev. Immunol. 10:1992;123-151.
13. During M. J., Naegele J. R., O'Malley K. L., Geller A. I. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
14. Fabry Z., Raine C. S., Hart M. S. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today. 15:1994;218-224.
15. Federoff H. J., Geschwind M. D., Geller A. I., Kessler J. A. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. natn. Acad. Sci. U.S.A. 89:1992;1636-1640.
16. Fukumoto T., McMaster W. R., Williams A. F. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class 1 antigens in rat thymus. Eur. J. Immunol. 12:1982;237-243.
17. Harms J. S., Splitter G. A. Interferon γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Human Gene Ther. 6:1995;1291-1297.
18. Hunig T., Wallyn H. J., Hartley J. K., Lawerzky A., Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. exp. Med. 169:1989;117-127.
19. Johnson P. A., Wang M. J., Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68:1994;6347-6362.
20. Kajiwara K., Byrnes A. P., Charlton H. M., Wood M. J. A., Wood K. J. Immune responses to adenovirus during gene transfer in the brain. Human Gene Ther. 8:1997;253-265.
21. Kass-Eisler A., Falck-Pedersen E., Elfenbein D. H., Alvira M., Buttrick P. M., Leinwand L. A. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:1994;395-402.
22. Kesari S., Lee V. M.-Y., Brown S. M., Trojanowski J. Q., Faser N. W. Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1. J. Neurosci. 16:1996;5644-5653.
23. Lachman R. H., Efstathiou S. Utilization of the herpes simplex virus type 1 latency associated regulatory region to drive stable reporter gene expression in the nervous system. J. Virol. 71:1997;3197-3207.
24. Lopez C. Genetics of natural resistance to herpes virus infections in mice. Nature. 258:1975;152-153.
25. MacLean U. L., Faree M., Robertson M., Harland J., Brown S.M. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the "a" sequence. J. gen. Virol. 72:1991;631-639.
26. MacLean A. R., Robertson L., McKay E., Brown S. M. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency. J. gen. Virol. 72:1991;2305-2310.
27. 134.5 mutant of herpes simplex virus 1. J. Virol. 71:1997;5560-5569.
28. Matyszak M. K., Perry V. H. Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Gu,rin. Neuroscience. 64:1995;967-977.
29. McGeorge A. J., Faull R. L. M. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
30. McKie E. A., Hope R. G., Brown S. M., MacLean A. R. Characterisation of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. J. gen. Virol. 75:1994;733-741.
31. Mitchell B. M., Stevens J. G. Neuroinvasive properties of herpes simplex virus type I glycoprotein variants are controlled by the immune response. J. Immunol. 156:1996;246-255.
32. Morrison L. A., Knipe D. M. Immunization with replication defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:1994;689-696.
33. Nash A. A., Cambouropoulos P. The immune response to herpes simplex virus. Semin. Virol. 4:1993;181-186.
34. Nash A. A., Leung K. N. and Wildy P. (1985) The T-cell mediated response of mice to herpes simplex virus. In The Herpesviruses (eds Roizman B. and Lopez C.), pp. 87-102. Plenum, New York.
35. Nash A. A., Phelan J., Gell P. G. H., Wildy P. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology. 43:1981;363-369.
36. Nguyen L. H., Knipe D. M., Finberg R. W. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66:1992;7067-7072.
37. Owens T., Renno T., Taupin V., Krakowski M. Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol. Today. 15:1994;566-571.
38. Paxinos G. (1995) The Rat Nervous System, Academic, New York.
39. Perry V. H., Bell M. D., Brown H. C., Matyszak M. K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5:1995;636-641.
40. Rabinowitz S. S., Gordon S. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. exp. Med. 174:1991;827-836.
41. Richards J. T., Kern E. R., Overall J. C., Glasgow L. A. Difference in neurovirulence among isolates of herpes simplex virus types 1 and 2 in mice using four routes of inoculation. J. infect. Dis. 144:1986;464-471.
42. Robinson A. P., White T. M., Mason D. W. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 57:1986;239-247.
43. Royce G. J. Laminar origin of cortical neurons which project upon the caudate nucleus: a horseradish peroxidase investigation in the cat. J. comp. Neurol. 205:1982;8-29.
44. Schmid D. S., Rouse B. T. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;57-87.
45. Simmons A., Tscharke D., Speck P. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Curr. Topics Microbiol. Immunol. 179:1992.
46. Simmons A., Tscharke D. C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. exp. Med. 175:1992;1337-1344.
47. Sloan D. J., Wood M. J., Charlton H. M. The immune response to intracerebral neural grafts. Trends Neurosci. 14:1991;341-346.
48. Smith P. M., Wolcott P. M., Chervenak R., Jennings S. R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology. 202:1994;76-88.
49. Taha M. Y., Clements G. B., Brown S. M. A variant of herpes simplex virus type 2 strain HG52 with a 1.5 kb deletion in RL between 0 to 0.02 and 0.81 to 0.83 map units is non-neurovirulent for mice. J. gen. Virol. 70:1989;705-716.
50. Taha M. Y., Clements G. B., Brown S. M. B. The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neurovirulence in mice. J. gen. Virol. 70:1989;3073-3078.
51. Townsend J. J. Infiltration of immune T cells in the brain of mice with herpes simplex virus-induced encephalitis. J. Neuroimmunol. 23:1985;195-201.
52. Valyi-Nagy T., Fareed M. U., O'Keefe J. S., Gesser R. M., MacLean A. R., Brown S. M., Spivack J. G., Fraser N. W. The herpes simplex virus type 1 strain 17+ gamma34.5 deletion mutant 1716 is avirulent in SCID mice. J. gen. Virol. 75:1994;2059-2063.
53. Veening J. G., Cornelissen F. M., Lieven P. A. J. M. The topical organization of the afferents to the caudatoputamen of the rat. A horseradish peroxidase study. Neuroscience. 5:1980;1253-1268.
54. Wood M. J. A., Byrnes A. P., McMenamin M., Kajiwara K., Vine A., Gordon I., Lang J., Wood K. J. and Charlton H. M. (1996) Immune responses to viruses: practical implications for the use of viruses for experimental and clinical gene therapy. In Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders (eds Lowenstein P. R. and Enquist L. W.), pp. 365-376. Wiley, Chichester.
55. Wood M. J. A., Byrnes A. P., Pfaff D. W., Rabkin S. D., Charlton H. M. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1:1994;283-291.
56. Wood M. J. A., Charlton H. M., Wood K. J., Kajiwara K., Byrnes A. P. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19:1996;497-501.
57. Woollett G. R., Barclay A. N., Puklavec M., Williams A. F. Molecular and antigenic heterogeneity of the rat leucocyte-common antigen from thymocytes and T and B lymphocytes. Eur. J. Immunol. 15:1985;168-173.
58. Wu L., Morahan P. S. Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;89-110.
59. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gonczol E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. natn. Acad. Sci. U.S.A. 91:1994;4407-4411.